You are here: Industry Insights > GSK

News List

GSK welcomes Gavi decision to fund the roll out of malaria vaccines for children FirstWordPharma
December 03, 2021
GlaxoSmithKline (GSK) plc today welcomed the decision of the Gavi Board to provide funding for the procurement and introduction of malaria vaccines into routine child immunisation programmes in Gavi eligible countries.
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community WorldPharmaNews
December 02, 2021
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in ...
GSK aim for HIV cure by 2030 PharmaTimes
December 01, 2021
Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future...
GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment WorldPharmaNews
November 22, 2021
GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced US government contracts totalling approximately $1 billion[1] (USD) to purchase sotrovimab...
GSK and Vir to supply Covid-19 antibody treatment doses to US Pharmaceutical-Business-Review
November 19, 2021
GlaxoSmithKline (GSK) and Vir Biotechnology have secured contracts from the US government for nearly $1bn to supply their Covid-19 antibody treatment, sotrovimab.
US agrees to procure doses of GSK-Vir’s Covid-19 therapy sotrovimab Pharmaceutical-Technology
November 19, 2021
The US Government has entered an agreement to procure doses of GlaxoSmithKline (GSK) and Vir Biotechnology’s experimental Covid-19 therapy, sotrovimab, for nearly $1bn.
Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19 WorldPharmaNews
November 16, 2021
GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase III trial...
GSK's Jemperli scores FDA nod for mismatch repair-deficient solid tumours firstwordpharma
August 18, 2021
GlaxoSmithKline said the FDA has expanded the label for Jemperli (dostarlimab-gxly) to include treatment of adults with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours.
GSK Files for Licensure of Priorix MMR Vaccine in the US drugs
August 10, 2021
GSK today announced it has submitted a Biologics License Application to the US Food and Drug Administration for Priorix (Measles, Mumps, and Rubella Virus Vaccine, Live) and is seeking approval for use in active immunization against infection by MMR.
GSK reports £8.1 billion in Q2 sales europeanpharmaceuticalreview
August 04, 2021
GSK announces “excellent” Q2 financial performance with growth across all segments – Pharmaceuticals, Vaccines, Consumer Healthcare.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page